{"url":"https://lda.senate.gov/api/v1/filings/23957e6a-eae0-4733-96ab-0fa6bf92e748/","filing_uuid":"23957e6a-eae0-4733-96ab-0fa6bf92e748","filing_type":"RR","filing_type_display":"Registration","filing_year":2015,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/23957e6a-eae0-4733-96ab-0fa6bf92e748/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michael Meirovitz","dt_posted":"2015-01-28T15:54:10-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"8941 Jefferson Highway","registrant_address_2":"Suite 200","registrant_different_address":null,"registrant_city":"Baton Rouge","registrant_state":"LA","registrant_zip":"70809","registrant":{"id":400671007,"url":"https://lda.senate.gov/api/v1/registrants/400671007/","house_registrant_id":null,"name":"TAUZIN CONSULTANTS, LLC","description":"​Government relations, business development, and business incubation firm.","address_1":"216 Landry Lane","address_2":null,"address_3":null,"address_4":null,"city":"Thibodaux","state":"LA","state_display":"Louisiana","zip":"70301","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"THOMAS TAUZIN","contact_telephone":"+1 917-992-0108","dt_updated":"2026-07-15T19:01:59.122115-04:00"},"client":{"id":194010,"url":"https://lda.senate.gov/api/v1/clients/194010/","client_id":277,"name":"COQUI RADIOPHARMACEUTICALS, CORP.","general_description":"Radiopharmaceutical company that focuses on creating a supply of radioisotopes in the US","client_government_entity":false,"client_self_select":null,"state":"FL","state_display":"Florida","country":"US","country_display":"United States of America","ppb_state":"FL","ppb_state_display":"Florida","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Expand the Nuclear Loan Guarantee Program to include medical products derived from low enrichment uranium.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":52797,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"TAUZIN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Expand the Nuclear Loan Guarantee Program to include medical products derived from low enrichment uranium.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":52797,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"TAUZIN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"ENG","general_issue_code_display":"Energy/Nuclear","description":"Expand the Nuclear Loan Guarantee Program to include medical products derived from low enrichment uranium.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":52797,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"TAUZIN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}